A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Organo Corporation engages in water treatment engineering and performance product businesses in Japan, Taiwan, China, Southeast Asia, and internationally. The company offers pure water systems, such as reverse osmosis (RO) systems, regenerative automatic and manual pure water systems, electric regeneration pure water systems, desktop and cabinet-type pure water systems, electrodeionization high-purity water systems, cartridge water purifiers, and two-stage RO systems; ultrapure water systems, including desktop and cabinet-type ultrapure water systems, and final polishing units; and other equipment comprising homogenizers, electroconductivity and resistivity meters, and ion exchange filters, as well as marine scrubber wastewater treatment and continuous aerobic granular sludge systems. It also provides water, wastewater, and RO water treatment chemicals; industrial filters consisting of micro filter, sanitary, polypropylene, and plastic housings, as well as micro filters; and commercial water purifiers. In addition, the company offers ultrapure and multi-functional water production systems, wastewater treatment systems, ultra pure ion exchange resin for purifying electronic materials, valuable resource recovery systems, and organic solvent refining systems; purified and UF water production and supply systems, water for injection production and supply systems, and pharmaceutical water system consulting services; water supply and sewage treatment facility products; condensate filters and demineralizers, reactor water and fuel pool cleanup, makeup water, and waste water treatment systems; and sugar refining and decolorization, sugar desalination, amino and acidic sugar refining, and sugar separation equipment. The company was formerly known as Japan Organo Co., Ltd. and changed its name to Organo Corporation in 1966. Organo Corporation was incorporated in 1941 and is headquartered in Koto, Japan.
Financial Summary
| Share Statistics | ORCRY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $3,619.9 | $3,989.3 | 62% |
|
| Shares Out (Mil) | 0.3 | 47.0 | 2% |
|
| Institutional Ownership | 49.4% | 73.6% | 23% |
|
| Float (Mil) | 24.6 | 59.5 | 32% |
|
| Beta | 1.25 | 1.13 | 73% |
|
| Avg Daily Volume (000s) | 0 | 190 | 0% |
|
| Price Change (52-week) |
na | 75.9% | na |
|
| Growth | ORCRY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 4.2% | 5.6% | 32% |
|
| Net Income (5yr) | 22.8% | 9.6% | 77% |
|
| EPS (5yr) | 22.8% | 11.5% | 72 |
|
| Dividends (5yr) | 37.3% | 1.6% | 83% |
|
| Cash Flow (5yr) | 14.9% | (16.7%) | 72% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | ORCRY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,117 | $2,212 | 52% |
|
| Net Income (TTM) (Mil) | $179 | $148 | 66% |
|
| EPS (TTM) | $3.885 | $1.200 | 82% |
|
| Operating Cash Flow (TTM) (Mil) | na | $223 | na |
|
| Net Cash Flow (TTM) (Mil) | na | $4 | na |
|
| Long-Term Debt (Q1) (Mil) | $38 | $441 | 37% |
|
| Enterprise Value (Q1) (Mil) | $3,957 | $4,450 | 59% |
|
| Valuation | ORCRY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.40 | na |
|
| P/E | na | 25.9 | na |
|
| Dividend Yield | na | 0.2% | na |
|
| PEG (5yr hist) | na | 1.5 | na |
|
| Ratios | ORCRY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 36.2% | 31.8% | 44% |
|
| Net Margin | 15.5% | 7.2% | 73% |
|
| ROA | 13.6% | 4.7% | 92% |
|
| ROE | 22.7% | 10.7% | 82% |
|
| Liabilities to Assets | 36.4% | 50.0% | 27% |
|
| F-Score | na | 5 | na |
|
Organo Corporation did not pass any screens on 9/2/2026.
